Imricor Medical Systems, Inc.

Equities

IMR

AU0000054942

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:34:49 2024-09-12 am EDT 5-day change 1st Jan Change
0.5100 AUD +3.03% Intraday chart for Imricor Medical Systems, Inc. -1.92% -10.53%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call
Imricor Medical Systems, Inc. Reports Earnings Results for the Half Year Ended June 30, 2024 CI
Transcript : Imricor Medical Systems, Inc., H1 2024 Earnings Call, Aug 28, 2024
Imricor Withdraws TGA Application, Plans for FDA Approval; Shares Fall 6% MT
First US Patient Treated with Imricor Medical Systems' Clinical Trial MT
Imricor Medical Systems, Inc. Appoints Jeffrey Leighton as Director CI
Imricor Medical Systems to Raise AU$35 Million From Placement MT
Imricor Medical Systems' VISABL-AFL Trial to Commence at Swiss Hospital MT
Croatia's Dubrava University Hospital Performs Second Case with Imricor's Products; Shares Rise 3% MT
Strong Domestic Inflation Data Push Down Australian Shares MT
Imricor Medical Wins Electrophysiology System Contract in Hungary MT
Imricor Medical Systems, Inc.'s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris CI
Imricor Medical Systems' 3D Mapping Trial Starts in France MT
Croatian Hospital Begins Use of Imricor Medical Systems' Cardiac Procedure Products MT
Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT CI
Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call
Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic MT
Imricor Medical Systems Announces Release of Certain Stocks from Voluntary Escrow MT
Transcript : Imricor Medical Systems, Inc., Q1 2024 Earnings Call, Apr 30, 2024
Imricor Medical Systems Secures First Catheter Order from Croatia's Dubrava University Hospital MT
Mining, Healthcare Stocks Lift Australian Benchmark MT
Imricor Medical Systems Gains Approval for Clinical Trial at Cardiovascular Institute of South Paris; Shares Up 7% MT
Amsterdam University Medical Center Resumes Atrial Flutter Procedures with Imricor's NorthStar Mapping System MT
Imricor Medical Systems Completes AU$6.4 Million Shortfall Share Issue MT
Imricor Medical Systems' NorthStar 3D Mapping System Obtains Approval for Use in VISABL-AFL Trial MT
Chart Imricor Medical Systems, Inc.
More charts
Logo Imricor Medical Systems, Inc.
Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.
Employees
0
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3415USD
Average target price
0.6380USD
Spread / Average Target
+86.83%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMR Stock
  4. News Imricor Medical Systems, Inc.
  5. First US Patient Treated with Imricor Medical Systems' Clinical Trial
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW